Latest News about RHHBY
Recent news which mentions RHHBY
3 Beaten-Down Biotech Stocks -- Can They Recover?
October 31, 2021
From Motley Fool
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market
October 29, 2021
From Motley Fool
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
From Motley Fool
From Motley Fool
Why Atea Pharmaceuticals Stock Got Crushed This Week
October 22, 2021
From Motley Fool
Why Ionis Pharmaceuticals Stock Is Down 13% This Week
October 22, 2021
From Motley Fool
From Benzinga
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
October 21, 2021
From InvestorPlace
Are These 2 Companies Next for Short Squeezes?
October 21, 2021
From Motley Fool
From Benzinga
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
Why Atea Pharmaceuticals Is Imploding Today
October 19, 2021
From Motley Fool
David v Goliath in The Race to Develop an Oral Therapy for COVID-19
October 19, 2021
From Benzinga
From Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
From Benzinga
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
October 18, 2021
From Motley Fool
Roche's Tecentriq Wins FDA Approval In Adjuvant Lung Cancer Setting
October 18, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
3 COVID-19 Pill Stocks to Watch
October 16, 2021
From Motley Fool
Why Relay Therapeutics Is Up 30% This Week
October 15, 2021
From Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
From Benzinga
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
From Motley Fool
From Benzinga
From Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
From Motley Fool
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.